Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121708) titled 'The impact of esketamine on the quality of recovery after spinal surgery' on April 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking Union Medical College Hospital
Condition:
"Lumbar Spinal stenosis" or "Lumbar spondylolisthesis"
Intervention:
Trial Group:Intraoperative infusion of esketamine loading dose at 0.2 mg/kg (esketamine 1 mg/mL dissolved in 50 mL normal saline)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Trial Group:62;Control Group:62;
Countries of Recruitment:
China
To know more, visit https:/...